Rescission Package Short Changes Global, American Health Security

The Infectious Diseases Society of America, the HIV Medicine Association the Pediatric Infectious Diseases Society and the Society for Healthcare Epidemiology of America call on Congress to reject legislative attempts, including House Resolution 3 introduced Wednesday evening, that advance the Trump administration’s rescissions package.

Bills Address Infectious Diseases Impacts of the Opioid Crisis

The Eliminating Opioid-Related Infectious Disease Act and the Substance Use Disorder Loan Repayment Act under consideration by the House Energy and Commerce Committee today recognize that responses to the national opioid epidemic must include responses to its accompanying public and individual health threats.

Statement on CDC Vital Signs Vector-borne Diseases Report

The Vital Signs report data released today by the Centers for Disease Control and Prevention (CDC) show significant increases in vector-borne diseases in the United States highlighting the need for improved strategies to protect patients and public health.

Bills Recognize Needs for Action, Workforce, to Address Opioid/ID Impacts

The Infectious Diseases Society of America, the HIV Medicine Association, and the Pediatric Infectious Diseases Society commend House and Senate panels approving legislation this week that demonstrated a commitment to confronting the opioid crisis comprehensively and effectively.

World Immunization Week Recognizes Gains Brought by Vaccines

World Immunization Week from April 24-30 gives us the opportunity to celebrate one of the greatest achievements of modern medicine. Safe and effective vaccines that protect individuals against diphtheria, hepatitis B, measles, mumps, pertussis, rubella, human papilloma virus,and polio have drastically limited the incidence of these serious, sometimes life-threatening diseases in many parts of the world.

World Bank, IMF Must Focus on Global Health Funding and Capacity

The Infectious Diseases Society of America appreciates the attention that the World Bank and International Monetary Fund will give to critical global health issues during their spring meetings and civil society forum.

Hank Tomlinson, Ph.D. to Lead CDC’s Global HIV and TB Efforts at Critical Time

The U.S. government response to the global impacts of HIV and tuberculosis is poised at a pivotal moment, in which we can seize the opportunity to end these devastating pandemics, or watch progress erode, infections increase, and our effective treatments compromised by growing drug resistance.

IDSA Welcomes Recommendations to Build Biomedical Research Workforce

The National Academies of Science, Engineering and Medicine report Breaking Through, released Thursday, represents an important first step toward ensuring that the United States has the scientific workforce needed to face 21st-century infectious disease challenges.

Managing Outbreaks to Antibiotic Resistance, ID Specialists Key to Quality Healthcare

Infectious diseases (ID) specialists play a vital role in many areas of healthcare but their compensation ranks towards the bottom compared to other physicians.

PEPFAR report serves as a beacon and a warning

The 2018 Annual Report to Congress released by the United States President’s Emergency Plan for AIDS Relief tells a story of remarkable progress and opportunity.

PEPFAR report serves as a beacon and a warning

The 2018 Annual Report to Congress released by the United States President’s Emergency Plan for AIDS Relief tells a story of remarkable progress and opportunity.

World Health Day highlights the value of leadership and partnerships

On World Health Day, the Infectious Diseases Society of America and the HIV Medicine Association appreciate the global leadership of the United States in responding to infectious disease threats that know no boundaries.